stella
beta
Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients — Stella
Recruiting
Back to Neuroendocrine Carcinomas (NEC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(4 sites)
South Korea
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Yonsei Severance Hospital, Seoul
View full record on ClinicalTrials.gov